Google has quietly launched a project with one of the nation’s largest nonprofit health systems in which it has gained access to millions of patient records, including names and birth dates, to help deliver more targeted medical treatment. The initiative,…
Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies
CAMBRIDGE, Mass. and RESEARCH TRIANGLE PARK, N.C., Nov. 14, 2019 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc., (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, and StrideBio, Inc., a leading developer of novel adeno-associated viral (AAV) based gene…
Merck’s Ervebo is the World’s First Approved Ebola Vaccine
The European Commission approved the world’s first Ebola vaccine. The vaccine is manufactured by Merck and has a trade name of Ervebo. “The European Commission’s marketing authorization of Ervebo is the result of an unprecedented collaboration for which the entire…
CROs Moving to Electronics, But Paper Still Prevalent, Survey Shows
While CROs are gung-ho on some new technologies to manage trials, they still rely heavily on paper-based systems, a new survey shows. Electronic data capture (EDC), electronic trial master files (eTMF) and clinical trial management systems (CTMS) are increasingly in…
Syneos Health and AiCure Announce Partnership to Optimize Patient Engagement and Trial Success First CRO Partnership to Provide Patient, Trial, and Site-Level AI-Driven Insights
MORRISVILLE, N.C. and NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) — Syneos Health®(Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and AiCure, an AI and advanced data analytics company, today announced a novel strategic partnership to drive faster, smarter trials to…
Pharma to increase spend on digital marketing – report
A third of pharma companies will be spending more than half of their marketing budget on digital channels over the next three years, according to a new report. The Indegene Pharma Marketer 2020 report predicted a shift in spend to…
Indian Govt gives go-ahead for 4 medical device parks
The government has given approval for setting up four medical device parks with a view to support Make in India initiative and provide world-class products at affordable price for treatment. The four parks will be set up in Andhra Pradesh,…
The Continuum of Misconduct: Stopping Unintentional Errors Before They Become Intentional Fraud
We’ve all heard the stories of deliberate data fraud in clinical trials: the investigator who created fictional subjects, the lab technician who duplicated test data, the coordinator who altered records. What makes people think they can get away with it?…
FDA Approves Celgene and Acceleron’s Treatment for Rare Blood Disease
The U.S. Food and Drug Administration (FDA) approved Celgene and Acceleron Pharma’s Reblozyl for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions. The approval marks the first approved treatment in…
In $660 Million Deal, Takeda Offloads Non-Core Assets to Germany’s STADA
Takeda Pharmaceutical will unload a portfolio of over-the-counter and prescription pharmaceutical products to Germany-based STADA Arsneimittel AG for$660 million as the company continues to pare down debt from its $62 billion acquisition of Shire. The portfolio of drugs sold to…
